Related Experiment Video
Updated: Apr 19, 2026

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
[ORALMEDIC® for treatment of aphthous stomatitis--possible side effects with repeated applications]
1Dept. of Oral Pathology and Oral, Medicine, Tel Aviv University, Tel Aviv, Israel.
Abstract:
ORALMEDIC® (HybenX, Epien Medical Inc., Minneapolis, MN, USA) is a relatively recent commercial agent designated for the treatment of recurrent aphthous stomatitis (RAS). It has the potential to safely and effectively reduce pain associated with RAS. We present two patients who used ORALMEDIC® to reduce pain caused by RAS lesions. Both patients developed side effects presenting as deep ulcerations with a necrotic base at the location where ORALMEDIC® has been repeatedly applied as pain did not diminish after the first application. One patient used ORALMEDIC® several times on the same lesion. However the other patient followed the manufacturer instructions when he successively used ORALMEDIC® stick twice over the same lesion. Patients were treated with systemic antibiotics and local antiseptic agents. The healing process of the ulcers was slow and has completed its course within six weeks. It is suggested that when dental surgeons recommend ORALMEDIC®, they should emphasize the importance of using this agent according to the manufacturer's instructions in order to minimize the risk for side effects.
Related Concept Videos
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Treatment of Ulcerative Colitis in IBD
Tonsillitis II: Management
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...

